(1.1-7.1%) per 9.0 ppb 15-64 years: 1.6% (0.5-2.8%) per 9.0 ppb 65+ years: No effect. () Meta-analysis of 5 cities - Brisbane, Canberra, Melbourne, Perth, Sydney. Low heterogeneity. lCD9: 460-519; ICDI0: J00-J99 (excluding R09.1, R09.8 1-hour maximum Asthma 1-14 years: 5.29% 2.6% (0.6-4.9%) per n/a n/a n/a No CRF (1.07-9.68%) per 29 50 ug/m3 Consistent evidence recommended. ppb () of positive () () associations, 2 Australian Sydney Pooled CRF from 4 particularly for studies have ICD9: 493 cities. asthma. shown no effects. 1-hour maximum 24-hour average () ?Age May use either No effect 0-29 years: 1.0243 Morgan et al () CRF () (1.0084-1.0405) per in a sensitivity Pooled CRF from 4 10 ppb analysis. Note the cities (Sydney, 30-99 years: 1.0141 restricted age Perth, Melbourne, (1.0042-1.0241) per group.
(1.1-7.1%) per 9.0 ppb 15-64 years: 1.6% (0.5-2.8%) per 9.0 ppb 65+ years: No effect. () Meta-analysis of 5 cities - Brisbane, Canberra, Melbourne, Perth, Sydney. Low heterogeneity. lCD9: 460-519; ICDI0: J00-J99 (excluding R09.1, R09.8 1-hour maximum Asthma 1-14 years: 5.29% (1.07-9.68%) per 29 ppb () Sydney ICD9: 493 1-hour maximum No effect () Pooled CRF from 4 cities (Sydney, Perth, Melbourne, 2.6% (0.6-4.9%) per 50 ug/m3 () () Pooled CRF from 4 cities. 24-hour average ?Age n/a n/a Consistent evidence of positive associations, particularly for asthma. () 0-29 years: 1.0243 (1.0084-1.0405) per 10 ppb 30-99 years: 1.0141 (1.0042-1.0241) per n/a No CRF recommended. 2 Australian studies have shown no effects. May use either Morgan et al () CRF in a sensitivity analysis. Note the restricted age group.
health-report.docx